Clinical trial
SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous…
NCT00098826 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00098826 |
|---|---|
| Title | SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes |
| Official title | Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13, q22) and 22 more |
| Intervention type | Drug, Other |
| Interventions | ispinesib, laboratory biomarker analysis, pharmacological study |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| Primary completion | May 1, 2008 |
| First posted | Dec 9, 2004 |
| Last update posted | Jan 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: